Libivirumab

Libivirumab is a human monoclonal antibody directed against the hepatitis B virus.[1][2]

Libivirumab
Monoclonal antibody
TypeWhole antibody
SourceHuman
TargetHepatitis B surface antigen
Clinical data
ATC code
  • none
Identifiers
CAS Number
ChemSpider
  • none
Chemical and physical data
FormulaC6598H10232N1788O2060S46
Molar mass149.04 kg/mol g·mol−1
 NY (what is this?)  (verify)

References
  1. WHO Drug Information
  2. Shouval, D; et al. (2006). "Anti-Viral Effects, Pharmacokinetics and Safety of Two Human Monoclonal Anti-Hbs (Libivirumab/Exbivirumab) Versus Hepatitis B Immune Globulin (Hbig) in Hepatitis B Virus (Hbv) in Liver Transplant (Lt) Recipients". Hepatology. 44 (4): 188A–700A [196A]. doi:10.1002/hep.21395. PMID 17001593.


This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.